Specifically, acute inflammation, steatosis, and fibrosis caused by NAFLD might aggravate the activation of HSCs and lead to CTGF upregulation in the non-alcoholic fatty liver from the brain-dead donor14,15,17. This evidence concerns the gene CCN2 and metabolic dysfunction-associated steatotic liver disease.